MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading ph...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase. |
---|---|
AbstractList | Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase. |
Author | Yan Philip Chartash Elliot Keith Peng Joanna Z Hoffman Rebecca S Granneman George Richard Paulson Susan K Taylor Lori K |
Author_xml | – fullname: Taylor Lori K – fullname: Hoffman Rebecca S – fullname: Peng Joanna Z – fullname: Granneman George Richard – fullname: Paulson Susan K – fullname: Chartash Elliot Keith – fullname: Yan Philip |
BookMark | eNqNyrsKwjAUANAMOvj6h4BzoK0BcYzmpgbSpNykriVIxKGkgfr_uPgBTmc5W7LKc04borrBBN0bYA-BWlwNUOk8UIRWd2CpckgDggjatjRYFafyjgzBiACSSu0dSkC_J-tXnJZ0-LkjRwXhdmepzGNaSnymnD7j4JuqPlecN_wi6tN_6wvdey_C |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2017044249A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2017044249A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:57:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2017044249A13 |
Notes | Application Number: US201514745092 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&CC=US&NR=2017044249A1 |
ParticipantIDs | epo_espacenet_US2017044249A1 |
PublicationCentury | 2000 |
PublicationDate | 20170216 |
PublicationDateYYYYMMDD | 2017-02-16 |
PublicationDate_xml | – month: 02 year: 2017 text: 20170216 day: 16 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | AbbVie Biotechnology Ltd |
RelatedCompanies_xml | – name: AbbVie Biotechnology Ltd |
Score | 3.081234 |
Snippet | Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&locale=&CC=US&NR=2017044249A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-K6tR0-DOnadKu03ejH2NtI2g4G0g1X8d_3Ejvd096SHByXwOWXX3J3AXjOmPGaIYyoS22ZIUHpFCordKZ2-wi-Rq_DDBntHoTmONXf58a8AR-7XBhZJ_RbFkdEj8rQ3yu5X2_-L7EcGVu5feErHFq_ucnAUWp2rPURskzFGQ7odOJMbMW2B2mshNGvTNeRbFjIlY7EQVpU2qezochL2eyDinsOx1PUV1YX0CjKFpzau7_XWnAS1E_e2Ky9b3sJbpD6iTf1qTqzIs8a-pQ4k5iSiI68gIYECR1JImolXjgiSejKPFpVfIqB2xNxvBgJH43iK3hyaWKPVTRo8Tf_RRrvW9-7hma5LosbILxf5OJhjbOc6abGOEcyw7s4mHeYrrFbaB_SdHdYfA9noitClDWzDc3q86t4QASu-KNcuB8weIQl |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3fS8MwEMePMcX5plPxx9SA0rfiuvUHPgzp2nSrtt1o07G3kXQdCNINV_Hf9xo33dPeQg5CErh8-SR3OYDHjBvPGcqIutAWGQJKO1d5rnO1Y6H4Gt02N2S0exiZw1R_nRrTGnxsc2HkP6Hf8nNE9KgM_b2U5_Xq_xLLlbGV6yfxjl3LF4_1XGVDx5qFkmUqbr9HxyN35CiO00sTJYp_bbqOsGEjKx1YCIUSlib9Ki9ltSsq3gkcjnG8ojyFWl40oeFsa6814SjcPHljc-N96zPwwjRg_jig6sSOfbsfUOKOEkpiOvBDGhEEOsJiajM_GhAWeTKPVq2KYuDxRFw_QeCjcXIODx5lzlDFCc3-1j9Lk93Zdy-gXiyL_BKIsPJ59bAm-JzrpsaFQJgRHeyct7mu8Sto7Rvper_5HhpDFgazwI_ebuC4MlXhyprZgnr5-ZXfohqX4k5u4g-DRocP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MULTIPLE-VARIABLE+DOSE+REGIMEN+FOR+TREATING+TNFalpha-RELATED+DISORDERS&rft.inventor=Taylor+Lori+K&rft.inventor=Hoffman+Rebecca+S&rft.inventor=Peng+Joanna+Z&rft.inventor=Granneman+George+Richard&rft.inventor=Paulson+Susan+K&rft.inventor=Chartash+Elliot+Keith&rft.inventor=Yan+Philip&rft.date=2017-02-16&rft.externalDBID=A1&rft.externalDocID=US2017044249A1 |